Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Schuster

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
AJR. American Journal of Roentgenology|June 9, 2016
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?Ayse Tuba Karagulle Kendi, Kelly R Magliocca, Amanda Corey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
Impact of <sup>18</sup>F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized TrialAshesh B Jani, Eduard Schreibmann, Peter J Rossi, et al.
The Journal of Urology|March 1, 2019
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate CancerBaowei Fei, Olayinka A Abiodun-Ojo, Akinyemi A Akintayo, et al.
Radiology|April 16, 2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CTDavid M Schuster, Bital Savir-Baruch, Peter T Nieh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2016
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory StudyFunmilayo I Tade, Michael A Cohen, Toncred M Styblo, et al.
Medical Physics|May 9, 2022
MRI-based prostate and dominant lesion segmentation using cascaded scoring convolutional neural networkZachary A Eidex, Tonghe Wang, Yang Lei, et al.
European Journal of Radiology|March 31, 2015
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?A Tuba Kendi, Amanda Corey, Kelly R Magliocca, et al.
Bioinformatics Advances|November 27, 2025
MutSeqR: an open source R package for standardized analysis of error-corrected next-generation sequencing data in genetic toxicologyAnnette E Dodge, Andrew Williams, Danielle P M LeBlanc, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Diuresis During <sup>18</sup>F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II TrialIsmaheel O Lawal, Aliza Mushtaq, Ashesh B Jani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
<sup>18</sup>F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate CancerOlayinka A Abiodun-Ojo, Akinyemi A Akintayo, Oladunni O Akin-Akintayo, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
AJR. American Journal of Roentgenology|June 9, 2016
Is There a Role for PET/CT Parameters to Characterize Benign, Malignant, and Metastatic Parotid Tumors?Ayse Tuba Karagulle Kendi, Kelly R Magliocca, Amanda Corey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 10, 2016
Impact of <sup>18</sup>F-Fluciclovine PET on Target Volume Definition for Postprostatectomy Salvage Radiotherapy: Initial Findings from a Randomized TrialAshesh B Jani, Eduard Schreibmann, Peter J Rossi, et al.
The Journal of Urology|March 1, 2019
Feasibility and Initial Results: Fluciclovine Positron Emission Tomography/Ultrasound Fusion Targeted Biopsy of Recurrent Prostate CancerBaowei Fei, Olayinka A Abiodun-Ojo, Akinyemi A Akintayo, et al.
Radiology|April 16, 2011
Detection of recurrent prostate carcinoma with anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid PET/CT and 111In-capromab pendetide SPECT/CTDavid M Schuster, Bital Savir-Baruch, Peter T Nieh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 9, 2016
Anti-3-18F-FACBC (18F-Fluciclovine) PET/CT of Breast Cancer: An Exploratory StudyFunmilayo I Tade, Michael A Cohen, Toncred M Styblo, et al.
Medical Physics|May 9, 2022
MRI-based prostate and dominant lesion segmentation using cascaded scoring convolutional neural networkZachary A Eidex, Tonghe Wang, Yang Lei, et al.
European Journal of Radiology|March 31, 2015
18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?A Tuba Kendi, Amanda Corey, Kelly R Magliocca, et al.
Bioinformatics Advances|November 27, 2025
MutSeqR: an open source R package for standardized analysis of error-corrected next-generation sequencing data in genetic toxicologyAnnette E Dodge, Andrew Williams, Danielle P M LeBlanc, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 23, 2025
Diuresis During <sup>18</sup>F-Flotufolastat (rhPSMA-7.3) PET/CT Improves Recurrence Detection After Prostatectomy: A Prospective Phase II TrialIsmaheel O Lawal, Aliza Mushtaq, Ashesh B Jani, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 8, 2019
<sup>18</sup>F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate CancerOlayinka A Abiodun-Ojo, Akinyemi A Akintayo, Oladunni O Akin-Akintayo, et al.
Pageof 18